tiprankstipranks
Trending News
More News >
CG Oncology, Inc. (CGON)
:CGON
US Market

CG Oncology, Inc. (CGON) Income Statement

Compare
246 Followers

CG Oncology, Inc. Income Statement

Last quarter (Q3 2025), CG Oncology, Inc.'s total revenue was $1.67M, an increase of 3774.42% from the same quarter last year. In Q3, CG Oncology, Inc.'s net income was $-43.81M. See CG Oncology, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.14M$ 204.00K$ 191.00K$ 10.36M
Gross Profit
$ 1.14M$ 204.00K$ 176.00K$ 10.35M
Operating Expenses
$ 115.81M$ 55.65M$ 35.42M$ 22.95M
Depreciation and Amortization
$ 32.00K$ 17.00K$ 15.00K$ 10.00K
EBITDA
$ -114.63M$ -55.43M$ -35.23M$ -12.38M
Operating Income
$ -114.67M$ -55.45M$ -35.25M$ -12.61M
Other Income/Expenses
$ 26.63M$ 6.84M$ -197.00K$ -233.00K
Pretax Income
$ -88.04M$ -48.61M$ -35.44M$ -12.84M
Net Income
$ -88.04M$ -48.61M$ -35.44M$ -12.84M
Per Share Metrics
Basic EPS
$ -1.41$ -1.02$ -0.66$ -0.28
Diluted EPS
$ -1.41$ -1.02$ -0.66$ -0.28
Weighted Average Shares Outstanding
62.50M 66.64M 66.64M 66.64M
Weighted Average Shares Outstanding (Diluted)
62.50M 66.64M 66.64M 66.64M
Currency in USD

CG Oncology, Inc. Earnings and Revenue History